Participate. Learn. Connect. 

Olink and the University of Leeds are proud to announce the launch of Allotype BioDiscovery, a new venture dedicated to advancing precision proteomics and translational research. 

Proteomics is taking the breakthroughs of genomics to the next level. As a vital force behind the next wave of scientific discovery, proteomics is transforming our understanding of disease mechanisms, early diagnosis and therapeutic development across many diseases and conditions - accelerating the path to personalized treatment. 

Join us for an exclusive in-person event where science meets impact. Explore how affinity-based proteomics is revolutionizing drug discovery, deepening our grasp of complex diseases, and shaping the future of healthcare. Connect with leading experts, see the latest innovations in action, and be part of the conversation that's redefining precision medicine. Come along and learn how to accelerate your proteomic discovery through strategic collaboration between academia, healthcare and drug discovery.

Date: October 14, 2025                                                               

Time: 12:00pm - 4:00pm  (Lunch and Refreshments provided)                       

Location: Nexus, University of Leeds

Address: Discovery Way, University of Leeds, Leeds, LS2 3AA

Agenda:

12:00pm - 1:00pm | Registration & Lunch

1:00pm - 3:00pm | Scientific Talks

3:00pm - 3:15pm | Closing Remarks

3:15pm - 4:00pm | Lab Tour & Networking

Why Attend?

• Explore how protein biomarkers are shaping precision medicine.
• Network with experts and peers in the areas of multiomics and proteomics 
• Discover how Allotype BioDiscovery can support your translational research and clinical development as an Olink Certified Service Provider.
  
  The event is free to attend, but registration is required. 
  Limited Seats Available – Secure Yours Today!